AMSBIO expands US operations

Published: 25-Apr-2014
Manufacturing Analysis Pharmaceutical

Opens North American headquarters in Cambridge, Massachusetts


AMS Biotechnology (AMSBIO), has opened a new North American headquarters in Cambridge, MA for its US subsidiary, AMSBIO LLC.

AMSBIO's President Alex Sim said the company's North American customer base has been growing strongly in recent years and from the new facility it will provide 'local informed service and support as well as next day delivery of a comprehensive range of enabling technology products'.

The US is the single largest market for the company's stem cell and regenerative medicine, glycobiology enzymes/substrates and tissue derived products. The company also provides solutions for studying cell motility, migration, invasion and proliferation to customers in the region.

AMSBIO serves the European market from facilities in Switzerland, Germany and the UK.

  • Companies:
  • AMS Biotechnology AMSBIO
See more

You may also like

Analysis

Tailored cryopreservation storage solutions for cell therapy manufacturing

Read more
CELLBANKER freezing media from AMSBIO is now available in customisable formats, seamlessly integrating into cell manufacturing processes with personalised formulations, volumes and packaging

Trending Articles

  1. Solvent recycler SPR-200 boosts sustainability in pharma labs Recycling up to 90% of solvent in isocratic HPLC improves lab efficiency and sustainability
  2. Neuraxpharm Group and Pharmathen partner to develop long-lasting psychiatric injectables The co-development deal aims to enhance patient compliance, with Pharmathen and Neuraxpharm holding rights to the product in North America and Europe, respectively
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    CDMO insights: development and manufacture of a highly potent OSD product In today’s pharmaceutical landscape, contract development and manufacturing organisations (CDMOs) are ubiquitous. Prior to the CDMO boom in the 1990s, however, this wasn’t the case
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be complicated. Here, the tablet experts Natoli explain how to develop tabletability, compactibility, and compressibility profiles
  5. BioMarin Pharmaceutical expands Cork targeted therapy manufacturing facility with new lab The Irish facility is responsible for the development and commercialisation of therapies that address genetic conditions, and this expansion will allow the company to enhance its approved medicine production capacity

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Analysis

Tailored cryopreservation storage solutions for cell therapy manufacturing

CELLBANKER freezing media from AMSBIO is now available in customisable formats, seamlessly integrating into cell manufacturing processes with personalised formulations, volumes and packaging
Analysis

High performance magnetic beads for immunoassays

AMSBIO has expanded its range of high-performance magnetic beads for use as detection labels in magnetic immunoassays or as a solid support phase in immunoassays
Analysis

Spatial biology multi-omics profiling tools

Leading life sciences products and services provider - AMSBIO announce the launch of a custom service providing access to a suite of powerful spatial biology multi-omics profiling tools
Analysis

Cost-effective customisable ELISA assay kits

AMSBIO has announced a new range of customisable ELISA assay kits designed to enable experienced researchers to achieve reliable and reproducible assay results.
Research & Development

Experimental cell lines help screening for CAR T therapies

AMSBIO has added new experimental cell lines to its CAR T cell research range
Pharmaceutical

Amsbio expands biotechnology portfolio

Wnt Signaling Pathway products and other lines grow
Analysis

ELISA-like Assay for Hyaluronic Acid

AMSBIO have launched the Hyaluronic Acid Quantification Kit, based on a highly specific and tightly binding protein to detect and measure hyaluronic acid, also known as hyaluronan or HA
Subscribe now